ITOS logo

iTeos Therapeutics, Inc. (ITOS)

Profile

Full Name

iTeos Therapeutics, Inc.

Ticker

NASDAQ: ITOS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

https://www.iteostherapeutics.com

Employees

173

Key Details

Price

$10.15

Market cap

$448.68M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$35.00M(+177.89% YoY)

Annual EPS

-$3.32(-5.40% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.15
    ITOS price is $10.15

    30-Day Relative Volume

    0.00
    ITOS 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    ITOS price change on Aug 29, 2025 is unknown

    Price YTD change

    +32.16%
    ITOS price is up +32.16% since January 1st

    Price 1-year change

    +0.2%
    ITOS price is up +0.2% year-on-year

    Price 3-year change

    -46.83%
    ITOS price is down -46.83% over the past 3 years

    Price Range

    Price All-time high

    $52.43
    ITOS price is currently -80.64% below its historical high of $52.43

    Price 3-year low

    $4.80
    ITOS price is currently +111.46% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $448.68M
    ITOS market capitalization is $448.68 million

    Market cap 3-year change

    -33.93%
    ITOS market capitalization is down -33.93% over the past 3 years

    Market cap All-time high

    $1.69B
    ITOS market capitalization is currently -73.42% below its historical high of $1.69 billion

    Market cap sector rank

    -
    ITOS market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +21.04%
    ITOS shares outstanding is up +21.04% year-on-year

    Shares Outstanding 3-Year Change

    +24.26%
    ITOS shares outstanding is up +24.26% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    ITOS beta is 0.88

    200-day SMA

    $8.29
    ITOS price is currently +22.43% above its 200-day simple moving average

    50-day SMA

    $10.14
    ITOS price is currently +0.15% above its 50-day simple moving average

    RSI

    55.00
    ITOS 14-day relative strength index is 55.00

    Volume

    0.00
    ITOS 30-day relative volume is 0.00

    ATR

    $0.06
    ITOS average true range is $0.06

    10-day Historical Volatility

    5.44%
    ITOS 10-day historical volatility is 5.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $35.00M
    ITOS annual revenue is $35.00 million

    Revenue Analysts estimate

    -
    ITOS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +177.89%
    ITOS annual revenue is up +177.89% year-on-year

    Revenue Sector rank

    -
    ITOS annual revenue is unknown

    EPS

    EPS

    -$3.32
    ITOS annual earnings per share is -$3.32

    EPS Analysts estimate

    -$3.84
    ITOS annual earnings per share is currently -13.54% lower than the consensus analysts' forecast

    EPS 1-year change

    -5.4%
    ITOS annual earnings per share is down -5.4% year-on-year

    EPS Sector rank

    -
    ITOS annual earnings per share is unknown

    Profit

    Gross profit

    $33.76M
    ITOS annual gross profit is $33.76 million

    Gross margin

    96.46%
    ITOS annual gross profit margin is 96.46%

    Operating profit

    -$154.32M
    ITOS annual operating income is -$154.32 million

    Operating margin

    -455.79%
    ITOS annual operating profit margin is -455.79%

    Net income

    -$134.41M
    ITOS annual net profit is -$134.41 million

    Net margin

    -384.04%
    ITOS annual net profit margin is -384.04%

    Expenses

    Total expenses

    $189.32M
    ITOS annual total expenses is $189.32 million

    Operating expenses

    $189.32M
    ITOS annual total operating expenses is $189.32 million

    Cost of goods sold

    $1.24M
    ITOS annual cost of goods sold is $1.24 million

    Selling, general & administrative expenses

    $49.08M
    ITOS annual SGA is $49.08 million

    Depreciation and amortization

    $1.24M
    ITOS annual depreciation & amortization is $1.24 million

    Interest expense

    $0.00
    ITOS annual interest expense is $0.00

    Income tax

    $14.07M
    ITOS annual income tax is $14.07 million

    EBIT & EBITDA

    EBIT

    -$154.32M
    ITOS annual earnings before interest & taxes is -$154.32 million

    EBITDA

    -$153.09M
    ITOS annual EBITDA is -$153.09 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $686.98M
    ITOS annual total assets is $686.98 million

    Non current assets

    $177.44M
    ITOS annual long term assets is $177.44 million

    Current assets

    $509.54M
    ITOS annual total current assets is $509.54 million

    Cash and cash equivalents

    $142.13M
    ITOS annual cash & cash equivalents is $142.13 million

    Accounts receivable

    $805.00K
    ITOS annual accounts receivable is $805.00 thousand

    Inventory

    $0.00
    ITOS annual inventory is $0.00

    Liabilities

    Total liabilities

    $96.68M
    ITOS annual total liabilities is $96.68 million

    Long term liabilities

    $56.32M
    ITOS annual total long term liabilities is $56.32 million

    Current liabilities

    $40.36M
    ITOS annual total current liabilities is $40.36 million

    Accounts payable

    $8.50M
    ITOS annual accounts payable is $8.50 million

    Debt

    Total debt

    $5.10M
    ITOS annual total debt is $5.10 million

    Total debt 1-year change

    -15.88%
    ITOS annual total debt is down -15.88% year-on-year

    Long term debt

    $3.76M
    ITOS annual long term debt is $3.76 million

    Short term debt

    $1.34M
    ITOS annual short term debt is $1.34 million

    Equity & Capital

    Shareholders equity

    $590.29M
    ITOS annual stockholders equity is $590.29 million

    Book value

    $590.29M
    ITOS annual book value is $590.29 million

    Retained earnings

    -$9.78M
    ITOS annual retained earnings is -$9.78 million

    Working capital

    $469.18M
    ITOS annual working capital is $469.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$98.18M
    ITOS annual cash flow from operations is -$98.18 million

    Cash from operations 1-year change

    +5.37%
    ITOS annual cash flow from operations is up +5.37% year-on-year

    Cash from investing

    -$131.15M
    ITOS annual cash flow from investing activities is -$131.15 million

    Cash from investing 1-year change

    -280.5%
    ITOS annual cash flow from investing activities is down -280.5% year-on-year

    Cash from financing

    $122.24M
    ITOS annual cash flow from financing activities is $122.24 million

    Cash from financing 1-year change

    +10883.02%
    ITOS annual cash flow from financing activities is up +10883.02% year-on-year

    CAPEX

    CAPEX

    $1.66M
    ITOS annual capital expenditures is $1.66 million

    CAPEX 1-year change

    -45.91%
    ITOS annual capital expenditures is down -45.91% year-on-year

    Free Cash Flow

    Free cash flow

    -$99.81M
    ITOS annual free cash flow is -$99.81 million

    Free cash flow 1-year change

    +6.47%
    ITOS annual free cash flow is up +6.47% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.46%
    ITOS annual gross profit margin is 96.46%

    Operating margin

    -455.79%
    ITOS annual operating profit margin is -455.79%

    Net margin

    -384.04%
    ITOS annual net profit margin is -384.04%

    ROA & ROE

    ROA

    -19.85%
    ITOS annual return on assets is -19.85%

    ROE

    -23.07%
    ITOS annual return on equity is -23.07%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ITOS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ITOS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.91
    ITOS price to book ratio is 0.91

    PB ratio Sector rank

    -
    ITOS price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    ITOS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ITOS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$61.62M
    ITOS enterprise value is -$61.62 million

    Enterprise value Sector rank

    -
    ITOS enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    0.31
    ITOS EV/EBITDA is 0.31

    EV/EBITDA Sector rank

    -
    ITOS EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    12.62
    ITOS annual current ratio is 12.62

    Quick ratio

    12.62
    ITOS annual quick ratio is 12.62

    Leverage

    Debt to equity

    0.01
    ITOS annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    ITOS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ITOS piotroski f-score value is unknown

    Altman Z-Score

    2.89
    ITOS altman z-score is 2.89

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 Wells Fargo
    Equal-Weight
    May 28, 25 Wells Fargo
    Equal-Weight
    May 28, 25 Wedbush
    Neutral
    May 14, 25 Wells Fargo
    Overweight
    May 14, 25 Piper Sandler
    Overweight
    May 14, 25 Leerink Partners
    Market Perform
    May 14, 25 HC Wainwright & Co.
    Neutral
    May 13, 25 JP Morgan
    Neutral
    Apr 29, 25 Wells Fargo
    Overweight
    Mar 6, 25 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with ITOS included

    Stocks above SMA 50
    • What is the ticker symbol for iTeos Therapeutics, Inc.?
    • Does iTeos Therapeutics, Inc. pay dividends?
    • What sector is iTeos Therapeutics, Inc. in?
    • What industry is iTeos Therapeutics, Inc. in?
    • What country is iTeos Therapeutics, Inc. based in?
    • When did iTeos Therapeutics, Inc. go public?
    • Is iTeos Therapeutics, Inc. in the S&P 500?
    • Is iTeos Therapeutics, Inc. in the NASDAQ 100?
    • Is iTeos Therapeutics, Inc. in the Dow Jones?
    • When was iTeos Therapeutics, Inc.'s last earnings report?
    • When does iTeos Therapeutics, Inc. report earnings?

    What is the ticker symbol for iTeos Therapeutics, Inc.?

    The ticker symbol for iTeos Therapeutics, Inc. is NASDAQ:ITOS

    Does iTeos Therapeutics, Inc. pay dividends?

    No, iTeos Therapeutics, Inc. does not pay dividends

    What sector is iTeos Therapeutics, Inc. in?

    iTeos Therapeutics, Inc. is in the Healthcare sector

    What industry is iTeos Therapeutics, Inc. in?

    iTeos Therapeutics, Inc. is in the Biotechnology industry

    What country is iTeos Therapeutics, Inc. based in?

    iTeos Therapeutics, Inc. is headquartered in United States

    When did iTeos Therapeutics, Inc. go public?

    iTeos Therapeutics, Inc.'s initial public offering (IPO) was on July 24, 2020

    Is iTeos Therapeutics, Inc. in the S&P 500?

    No, iTeos Therapeutics, Inc. is not included in the S&P 500 index

    Is iTeos Therapeutics, Inc. in the NASDAQ 100?

    No, iTeos Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is iTeos Therapeutics, Inc. in the Dow Jones?

    No, iTeos Therapeutics, Inc. is not included in the Dow Jones index

    When was iTeos Therapeutics, Inc.'s last earnings report?

    iTeos Therapeutics, Inc.'s most recent earnings report was on May 12, 2025

    When does iTeos Therapeutics, Inc. report earnings?

    The next expected earnings date for iTeos Therapeutics, Inc. is November 12, 2025
    On this page